Key facts
- Lotus Health AI’s last known valuation is $147.0M (Feb 2026).
- It has raised $40.0M; the latest was Early Stage VC ($35.0M) in Feb 2026.
- Notable investors include Andreessen Horowitz, Sequoia Capital, Kleiner Perkins, CRV, Wormhole Capital — 13 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 13 names
- ·Watchlist + deal alerts for Lotus Health AI
- ·The full record, as it builds
Funding rounds
No funding rounds for Lotus Health AI are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Lotus Health AI
Developer of advanced healthcare analytics technology designed to improve patient outcomes through data-driven information. The company offers features such as predictive modeling, real-time health monitoring, and personalized treatment recommendations, enabling healthcare providers and organizations to improve clinical decision-making, optimize resource allocation, and deliver tailored care plans that address individual patient needs effectively.
- Sector
- Healthcare
- HQ
- Covina, CA, United States
- Founded
- 2020
- Employees
- 8
- Website
- lotus.ai/
- Ownership
- Privately Held (backing)
Lotus Health AI doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Lotus Health AI shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Lotus Health AI in its N-PORT filings yet. We sweep new filings monthly.